IP Library › Granted Patent US 12,409,269
Granted Patent B2
US 12,409,269 · App. 19/031,862 · Granted Sep 9, 2025

Tracking medication usage and supply chain event using networked intelligent injection devices

Inventors: Jeremy Corbett (Lexington, KY); John Spencer (Lexington, KY); Nathaniel Mitchell (Nicholasville, KY)
Assignee: DATADOSE, LLC
A61M5/172G16H20/17A61M5/20A61M2205/3553A61M2205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,409,269
App. No.
19/031,862
Granted
Sep 9, 2025
Kind
B2
Abstract

A method, computer program product, and computer system for a cloud-based medication tracking system. The system may include a plurality of intelligent injection devices across multiple healthcare facilities, each having: a barrel in fluid communication with a needle, a piston including a plunger, a microprocessor, a wireless communication module a supply chain tracking system configured to: monitor distribution of an injectable medication, verify availability of the injectable medication, track a global medication delivery pattern relating to the injectable medication, a machine learning system trained to: analyze medication usage data across healthcare entities, predict a supply chain event, optimize an inventory level, and improve a distribution datum.

Claims (58)

1. A cloud-based medication tracking system, comprising:

a plurality of intelligent injection devices across multiple healthcare facilities,

each having:

a barrel in fluid communication with a needle;

a piston comprising a plunger;

a microprocessor coupled to one or more sensors of the respective intelligent injection devices, the microprocessor configured to report data associated with the respective intelligent injection devices;

a wireless communication module configured to transmit the data associated with the respective intelligent injection devices to a supply chain tracking system;

the supply chain tracking system configured to receive, via the wireless communication module, the data associated with the plurality of intelligent injection devices, the supply chain tracking system further configured to process the data to:

monitor distribution of an injectable medication from the plurality of intelligent injection devices;

verify availability of the injectable medication from at least one of the plurality of intelligent injection devices and the supply chain tracking system;

track a global medication delivery pattern relating to the injectable medication from the plurality of intelligent injection devices;

a machine learning system trained to process the data associated with the respective intelligent injection devices to:

analyze medication usage data from the plurality of intelligent injection devices across healthcare entities;

predict a supply chain event from the plurality of intelligent injection devices;

optimize an inventory level from the plurality of intelligent injection devices; and

improve a distribution datum from the plurality of intelligent injection devices.

2. The cloud-based medication tracking system of claim 1 , wherein the supply chain tracking system employs blockchain verification.

3. The cloud-based medication tracking system of claim 1 further comprising a predictive analytics dashboard.

4. The cloud-based medication tracking system of claim 1 , wherein a digital twin system provides real-time simulation capabilities.

5. The cloud-based medication tracking system of claim 1 , wherein machine learning includes deep learning neural networks.

6. The cloud-based medication tracking system of claim 1 , wherein verification includes expiration date tracking.

7. The cloud-based medication tracking system of claim 1 , wherein patterns include geographic distribution analysis.

8. The cloud-based medication tracking system of claim 1 further comprising real-time shortage alerts.

9. The cloud-based medication tracking system of claim 1 , wherein analysis includes demographic usage patterns.

10. A networked medication usage analysis system, comprising:

multiple intelligent injection devices across a plurality of healthcare entities, each respective intelligent injection device coupled to a microprocessor, one or more sensors, and a wireless communication module, the microprocessor configured to report data, measured by the one or more sensors, associated with each respective intelligent injection devices, the wireless communication module configured to send the data to a digital twin system;

the digital twin system configured to:

model a medication usage pattern based upon the data from the multiple intelligent injection devices;

simulate a supply chain process based upon at least one of the data from the multiple intelligent injection devices and a custody and supply chain management system;

predict an inventory event based upon the data from the multiple intelligent injection devices;

enable coordinated distribution action across at least two healthcare entities among the plurality of healthcare entities based upon at least one of the data from the multiple intelligent injection devices and the custody and supply chain management system;

wherein a machine learning system associated with the multiple intelligent injection devices is configured to:

analyze global medication administration data based upon the data from the multiple intelligent injection devices;

detect a usage trend based upon the data from the multiple intelligent injection devices;

forecast a demand based upon the data from the multiple intelligent injection devices;

the custody and supply chain management system associated with the multiple intelligent injection devices configured to:

track a medication delivery based upon at least one of the data from the multiple intelligent injection devices and the custody and supply chain management system;

monitor an inventory level based upon at least one of the data from the multiple intelligent injection devices and the custody and supply chain management system;

detect a supply chain error based upon at least one of the data from the multiple intelligent injection devices and the custody and supply chain management system; and

detect a fraud event relating to the medication delivery based upon at least one of the data from the multiple intelligent injection devices and the custody and supply chain management system.

11. The networked medication usage analysis system of claim 10 , wherein simulation includes disaster response scenarios.

12. The networked medication usage analysis system of claim 10 , wherein fraud detection includes pattern recognition algorithms.

13. The networked medication usage analysis system of claim 10 , wherein the digital twin system includes multi-facility inventory optimization.

14. A medication supply chain optimization system, comprising:

networked intelligent injection devices across facilities, each respective networked intelligent injection device coupled to a microprocessor, one or more sensors, and a wireless communication module, the microprocessor configured to report data, measured by the one or more sensors, associated with each respective networked intelligent injection devices, the wireless communication module configured to send the data to a transaction intelligence system;

the transaction intelligence system configured to:

verify supply chain supply of a medication based upon at least one of the data from the networked intelligent injection devices and a supply chain tracking system;

provide financial prediction relating to the supply chain supply of the medication based upon at least one of the data from the networked intelligent injection devices and the supply chain tracking system;

an artificial intelligence system trained to:

analyze a medication usage pattern based upon the data from the networked intelligent injection devices;

predict a regional demand for the medication based upon the data from the networked intelligent injection devices; and

optimize a planned distribution of the medication based at least in part on the predicted demand.

15. The medication supply chain optimization system of claim 14 , wherein the artificial intelligence system employs natural language processing.

16. The medication supply chain optimization system of claim 14 further comprising automated compliance documentation.

17. The medication supply chain optimization system of claim 14 further comprising regulatory compliance verification.

18. The medication supply chain optimization system of claim 14 wherein prediction includes market dynamics analysis.

19. The medication supply chain optimization system of claim 14 further comprising seasonal demand forecasting.

20. The medication supply chain optimization system of claim 14 further comprising automated supplier communication protocols.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: CORBETT, JEREMY; SPENCER, JOHN; MITCHELL, NATHANIEL
To: DATADOSE, LLC
Reel/Frame 070290/0218 →
Continuity (7)
Continuation 19030829 · Jan 17, 2025
Continuation 17724177 · Apr 19, 2022
Continuation 16131749 · Sep 14, 2018
Continuation In Part 17926157
Provisional Application 63715505 · Nov 1, 2024
Provisional Application 63028182 · May 21, 2020
Related Publication 20250186694A1 · Jun 12, 2025
References Cited (65)
US 4950246A · Muller · 1990 [cited by examiner]
US 7300418B2 · Zaleski · 2007 [cited by applicant]
US 9623191B2 · Uber et al. · 2017 [cited by applicant]
US 12260959B1 · Minetti · 2025 [cited by examiner]
US 20010047281A1 · Keresman, III et al. · 2001 [cited by applicant]
US 20030110060A1 · Clementi · 2003 [cited by applicant]
US 20070179453A1 · Lim et al. · 2007 [cited by applicant]
US 20070225653A1 · Lim et al. · 2007 [cited by applicant]
US 20130338628A1 · Robertson et al. · 2013 [cited by applicant]
US 20140074454A1 · Brown et al. · 2014 [cited by applicant]
US 20140207099A1 · Nagar · 2014 [cited by examiner]
US 20150174342A1 · Mitrosky et al. · 2015 [cited by applicant]
US 20160243318A1 · Despa et al. · 2016 [cited by applicant]
US 20160259913A1 · Yu et al. · 2016 [cited by applicant]
US 20170076060A1 · Pilkington et al. · 2017 [cited by applicant]
US 20170095638A1 · Young et al. · 2017 [cited by applicant]
US 20170119969A1 · McCullough et al. · 2017 [cited by applicant]
US 20170136185A1 · Rios · 2017 [cited by examiner]
US 20170146381A1 · Eckel et al. · 2017 [cited by applicant]
US 20170245943A1 · Foster et al. · 2017 [cited by applicant]
US 20170325091A1 · Freeman et al. · 2017 [cited by applicant]
US 20180085517A1 · Laurence et al. · 2018 [cited by applicant]
US 20180133400A1 · Almoumen · 2018 [cited by applicant]
US 20180182491A1 · Belliveau et al. · 2018 [cited by applicant]
US 20180193564A1 · Dahmani · 2018 [cited by applicant]
US 20180333543A1 · Diaz et al. · 2018 [cited by applicant]
US 20180369488A1 · Carlsson et al. · 2018 [cited by applicant]
US 20190054247A1 · Dantsker et al. · 2019 [cited by applicant]
US 20190282761A1 · Wilson et al. · 2019 [cited by applicant]
US 20200061301A1 · Hatamian et al. · 2020 [cited by applicant]
US 20200086046A1 · Corbett et al. · 2020 [cited by applicant]
US 20200093993A1 · O'Rourke et al. · 2020 [cited by applicant]
US 20210008294A1 · Gentz · 2021 [cited by examiner]
US 20220023391A1 · Michelich · 2022 [cited by examiner]
US 20220031956A1 · Helmer · 2022 [cited by examiner]
US 20230414432A1 · Augustine · 2023 [cited by examiner]
US 20230414433A1 · Augustine · 2023 [cited by examiner]
US 20240157045A1 · Kostal · 2024 [cited by examiner]
US 20250050014A1 · Shin · 2025 [cited by examiner]
CA 3140408A1 · 2020 [cited by applicant]
EP 3991771A1 · 2022 [cited by applicant]
WO 2016210404A1 · 2016 [cited by applicant]
WO 2017156523A1 · 2017 [cited by applicant]
WO 2018009509A2 · 2018 [cited by applicant]
WO 2018106475A1 · 2018 [cited by applicant]
WO 2020236481A1 · 2020 [cited by applicant]
WO 2021237085A1 · 2021 [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/724,177 dated Apr. 21, 2025, 9 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,780 dated May 19, 2025, 6 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,836 dated Apr. 25, 2025, 6 pages. [cited by applicant]
Restriction Requirement Office Action for U.S. Appl. No. 19/031,854 dated May 9, 2025, 6 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,940 dated Apr. 11, 2025, 25 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 19/031,940 dated Jul. 3, 2025, 13 pages. [cited by applicant]
Extended European Search Report, Application No. 21808546.2, dated May 23, 2024, 8 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/724,177, dated Apr. 11, 2024, 11 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/724,177, dated Oct. 22, 2024, 13 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/131,749, dated Apr. 1, 2020, 9 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/131,749, dated Oct. 1, 2020, 11 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/131,749, dated Mar. 2, 2021, 13 pages. [cited by applicant]
Office Action for U.S. Appl. No. 16/131,749, dated Sep. 16, 2021, 10 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/131,749, dated Jan. 13, 2022, 7 pages. [cited by applicant]
Written Opinion of the International Searching Authority for Application No. PCT/US21/33646, dated Oct. 20, 2021, 10 pages. [cited by applicant]
International Search Report for Application No. PCT/US21/33646, dated Oct. 20, 2021, 4 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 19/031,836 dated Jul. 18, 2025, 17 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 19/031,854 dated Jul. 28, 2025, 32 pages. [cited by applicant]